Gordon Moe

MD, MSc

Investigator

Biography

My clinical research activities involve the assessment of the use of biomarker including B-type natriuretic peptide and new biomarkers in the management of acute and chronic heart failure, as well as the quality of care in heart failure. I am also interested in the assessment of the interaction of ethnicity with cardiovascular disease.

Recent Publications

  1. Lee, C, Chow, CM, Yan, AT, Moe, GW, Tu, JV, Chu, JY et al.. Awareness of Warning Symptoms of Heart Disease and Stroke: Results of a Follow-up Study of the Chinese Canadian Cardiovascular Health Project. CJC Open. 2021;3 (6):741-750. doi: 10.1016/j.cjco.2021.01.014. PubMed PMID:34169253 PubMed Central PMC8209403.
  2. Chu, JY, Kaliwal, Y, Koh, M, Chen, R, Chow, CM, Ko, DT et al.. COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES. Can J Neurol Sci. 2021; :1-29. doi: 10.1017/cjn.2021.148. PubMed PMID:34162448 .
  3. Fuery, MA, Chouairi, F, Januzzi, JL, Moe, GW, Caraballo, C, McCullough, M et al.. Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure. JACC Heart Fail. 2021;9 (7):497-505. doi: 10.1016/j.jchf.2021.02.011. PubMed PMID:33992564 .
  4. McDonald, M, Virani, S, Chan, M, Ducharme, A, Ezekowitz, JA, Giannetti, N et al.. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction. Can J Cardiol. 2021;37 (4):531-546. doi: 10.1016/j.cjca.2021.01.017. PubMed PMID:33827756 .
  5. Writing Group, Virani, SA, Zieroth, S, Bray, S, Ducharme, A, Harkness, K et al.. The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey. CJC Open. 2020;2 (3):151-160. doi: 10.1016/j.cjco.2020.03.001. PubMed PMID:32462129 PubMed Central PMC7242502.
  6. Rabi, DM, McBrien, KA, Sapir-Pichhadze, R, Nakhla, M, Ahmed, SB, Dumanski, SM et al.. Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2020;36 (5):596-624. doi: 10.1016/j.cjca.2020.02.086. PubMed PMID:32389335 .
  7. O'Meara, E, McDonald, M, Chan, M, Ducharme, A, Ezekowitz, JA, Giannetti, N et al.. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. Can J Cardiol. 2020;36 (2):159-169. doi: 10.1016/j.cjca.2019.11.036. PubMed PMID:32036861 .
  8. Nerenberg, KA, Zarnke, KB, Leung, AA, Dasgupta, K, Butalia, S, McBrien, K et al.. Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2018;34 (5):506-525. doi: 10.1016/j.cjca.2018.02.022. PubMed PMID:29731013 .
  9. Ezekowitz, JA, O'Meara, E, McDonald, MA, Abrams, H, Chan, M, Ducharme, A et al.. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Can J Cardiol. 2017;33 (11):1342-1433. doi: 10.1016/j.cjca.2017.08.022. PubMed PMID:29111106 .
  10. Leung, AA, Daskalopoulou, SS, Dasgupta, K, McBrien, K, Butalia, S, Zarnke, KB et al.. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Can J Cardiol. 2017;33 (5):557-576. doi: 10.1016/j.cjca.2017.03.005. PubMed PMID:28449828 .
Search PubMed

Affiliations & Other Activities

  • Director, Heart Failure Program and Biomarker Laboratory, Cardiology, St. Michael’s Hospital
  • Professor, Department of Medicine, St. Michael’s Hospital
X